Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

100,00  excl. 19% VAT

Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
Myristoyl-PKC ζ (113-125)/ζ-Pseudosubstrate Inhibitory Peptide (ZIP)

3403-v 0.5 mg | 100.00 EUR

Myristoylated Cell Permeable PKCζ Pseudosubstrate Inhibitor

Myristoyl- Ser- Ile- Tyr- Arg- Arg- Gly- Ala- Arg- Arg- Trp- Arg- Lys- Leu
(Trifluoroacetate Form)

(M.W. 1928.40) C90H154N30O17

Synthetic Product

Manufacturer: Peptide Institute Inc.

The purity is guaranteed to be higher than 99% by HPLC

References:

  1. C. Laudanna, D. Mochly-Rosen, T. Liron, G. Constantin and E.C. Butcher, J. Biol. Chem., 273, 30306 (1998) (Pharmacol.)
  2. S. Lim, J.W. Choi, H.S. Kim, Y.-H. Kim, K. Yea, K. Heo, J.H. Kim, S.-H. Kim, M. Song, J.I. Kim, S.H. Ryu and P.-G. Suh, Life Sci., 82, 733 (2008) (Biochem.)
  3. T. Hirose, D. Satoh, H. Kurihara, C. Kusaka, H. Hirose, K. Akimoto, T. Matsusaka, I. Ichikawa, T. Noda and S. Ohno, PLoS ONE, 4, e4194 (2009) (Pharmacol. & Histochem.)
  4. P.V. Migues, O. Hardt, D.C. Wu, K. Gamache, T.C. Sacktor, Y.T. Wang and K. Nader, Nat. Neurosci., 13, 630 (2010) (Pharmacol.)